Investor Relations


In addition to significant public funding CorTec has raised 3 rounds of financing.

The following page introduces you to our current investors.

learn more


Do you have any questions about our company or our technology?

We appreciate your feedback.

go to the contact page

About the Company

CorTec is a limited liability company founded in 2010. The company is located in Freiburg and currently has a staff of about 25 employees.

Innovations in Technology and Therapy

CorTec is developing the globally most efficient implant for long-term recording and stimulation of brain activity. The CorTec Brain Interchange technology opens up new ways of neurotherapy, as it is monitoring itself. For the first time, a system of this kind is able to adjust its therapeutic activities to the patient’s needs.

This technology enables the brain to communicate with the outside world and allows the outside world to interact with the brain. It thus constitutes a direct point of intersection between technology and the brain (a brain-machine interface).

Closed-loop systems have a promising future on the rapidly growing market of neuroprosthetics. CorTec will gradually seize this market as innovation leader. Market launch of the first products is imminent.


In spring 2016 CorTec closed a series B financing. Mangold Invest could be attracted as a new investor whilst also the majority of the previous investors participated. In addition to their investment, the company is funded by public subsidies mainly from the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF). CorTec is involved in several projects with partners from industry and research that contribute to the further development of CorTec’s technology.